Cyclacel suspends quarterly cash dividend on 6% Convertible Preferred Stock

Bio Green Med Solution, Inc.

Board resolved on Sept 4, 2024 to suspend Nov 1, 2024 quarterly dividend on Preferred Stock (CYCCP).
Future dividend payments will be evaluated on a quarterly basis by the Board.
Preferred stock carries 6% convertible exchangeable terms; suspension may signal liquidity concerns.
No change to common stock dividend (if any) or other obligations mentioned.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.